Biological models | cell culturing strategy | titer, viability, stability | expert screening strategies | real time information sharing | rapid transition to development
Selecting the right cell line, that can deliver quality product for you efficiently, is a key decision on the journey of your medicine to patients. It is critical that the cell line you select will fit biological model and make cell culturing straightforward.
We collaborate closely with you on this step, using our expert screening strategies to help rapidly select a final clonal cell line that can deliver breakthrough performance for process performance and product attributes. We screen multiple cell lines and cell platforms simultaneously, and share full titer, viability and stability information with you in real time.
This fast and collaborative approach ensures analytical and process development activities start sooner providing you the clarity needed to drive CMC activities that will effectively support clinical needs.
Schedule a workshop
Meet one-on-one with our experts to discuss your development and manufacturing challenges and our approach to accelerating your medicines through CMC hurdles.